3 keys to a higher value launch for IVD

Amanda Brantner, Ximedica Launching a new IVD technology can involve many hurdles and risks, but investment dollars abound for technologies that can demonstrate significant value in the healthcare market. “Investment and fundraising in the healthcare ecosystem saw a banner first half of 2017, driven in part by advancements in artificial intelligence and machine learning for

Navigating the FDA for connected devices

As connectivity features become increasingly prevalent, developers are tasked with accounting for regulatory implications in increasingly long-term plans. Aidan Petrie, Ximedica Let’s imagine a product that dispenses a drug for eczema. At its most basic, the dispenser is little more than a package for the primary drug container and so falls under some medical packaging

Webinar: How to innovate without increasing your risk

This webinar was presented live on Tuesday, Nov. 14, 2017. Click below to watch on demand.     Early identification and mitigation of programmatic risk elements is the key to predictable, efficient execution.  Ximedica has developed and refined its early phase development process to achieve this goal.  In the session we will demonstrate the tools

How medtech can create value in connected care

A cost-conscious healthcare system is increasingly driving toward value, creating both a challenge and an opportunity for medtech. There is a big difference, though, between what is an intuitively good idea in a care setting and what will actually resonate with hospital systems. Influential designer Aidan Petrie, who was a recent presenter at DeviceTalks Minnesota, discusses the complexities of

Unpacking ‘value’ in medical device development

The word “value” is a loaded term. At every stage of healthcare, it takes on different meanings. But above all, it has become, alongside the term “innovation,” the most sought after attribute for medical technology. “Most doctors are looking for value to patients and outcomes,” explains Bill Evans, SVP Innovation at Bridge Design, a Ximedica

Ximedica tapped to advise Cambridge MedSpace incubator

Ximedica said today it inked a strategic partnership deal with healthcare technology incubator Cambridge MedSpace. Through the deal, Providence, R.I.-based Ximedica will provide personalized guidance and advisory services to the incubator, which the company touts it has developed for over 30 years. “We know that healthcare technologies face unique challenges; particularly the standards of the

Accel Biotech picked up by Ximedica

Medtech developer Ximedica said today it acquired Los Gatos, Calif.-based medtech design firm Accel Biotech for an undisclosed amount. Ximedica said the acquisition will expand its west coast presence, complementing last year’s acquisition of San Francisco-based Bridge Design. “The acquisition of Accel Biotech deepens the capability, reach and scale of Ximedica’s comprehensive development offering into

Ximedica picks up Bridge Design

Ximedica, a Medtech development firm, has acquired San Francisco-based Bridge Design for an undisclosed amount. “This partnership has been formed to broaden the strength, reach and scale of Ximedica’s comprehensive development offering,” said Randall Barko, Ximedica president and CEO, in prepared remarks. “Ximedica brings the regulated systems, procedures and expertise to complement Bridge Design’s 2-plus decades of